Legislators
Bills
Statements
Represent

H.R.2315: Preserving Access to Orphan Drugs Act of 2013

About this Bill

This bill was introduced in the 113th Congress
This bill is primarily about health
You can read the bill
Sponsor Jim Gerlach, R-Pa.
Total Cosponsors 53 (18 Democrats, 35 Republicans)
Introduced June 11, 2013
Latest Major Action July 25, 2013
See it on GovTrack
See it on C-SPAN

Bill Progress

  • Bill introduced in the House   
  • Bill passed in the House   
  • Bill passed in the Senate   
  • Bill signed into law

Bill Summary

Preserving Access to Orphan Drugs Act of 2013 - Amends the Patient Protection and Affordable Care Act (PPACA) to exclude any drug or biological product which is approved or licensed by the Food and Drug Administration (FDA) for marketing solely for one or more rare diseases or conditions (orphan drug) from the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million.

Makes this Act effective as if included in PPACA.

(Source: Congressional Research Service)

Bill Actions

Date Description
July 25, 2013 Referred to House Energy and Commerce
July 25, 2013 Referred to House Ways and Means
June 14, 2013 Referred to the Subcommittee on Health.
June 11, 2013 Referred to House Ways and Means
June 11, 2013 Referred to House Energy and Commerce